Former Fortive CEO James Lico joins PTC's board of directors

Investing.comMonday, October 13, 2025 at 12:44:51 PM
Former Fortive CEO James Lico joins PTC's board of directors
James Lico, the former CEO of Fortive, has joined the board of directors at PTC, a move that is expected to enhance the company's leadership and strategic direction. Lico's extensive experience in the technology sector will bring valuable insights to PTC as it continues to innovate and expand its offerings. This appointment is significant as it reflects PTC's commitment to strengthening its governance and leveraging industry expertise to drive growth.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
AC Milan Reports Record Revenue, Third Consecutive Year Of Profit
PositiveFinancial Markets
AC Milan has announced record revenue for the 2024/25 fiscal year, marking its third consecutive year of profit. This achievement highlights the club's strong financial management and growth, which is crucial for maintaining competitiveness in Serie A and European competitions. Such financial stability not only benefits the club but also enhances its reputation among fans and potential investors.
Latest from Financial Markets
Apple TV Subtracts the + in a Quiet Rebrand
NeutralFinancial Markets
Apple has decided to drop the '+' from its Apple TV branding, signaling a subtle rebranding effort. This change reflects the company's strategy to streamline its services and focus on enhancing user experience. As the streaming landscape becomes increasingly competitive, this move could help Apple clarify its offerings and strengthen its position in the market.
TD Cowen lowers Beyond Meat stock price target to $0.80 on dilution
NegativeFinancial Markets
TD Cowen has lowered its price target for Beyond Meat's stock to $0.80, citing concerns over dilution. This significant reduction reflects ongoing challenges for the plant-based meat company, which has struggled to maintain investor confidence amid increasing competition and market pressures. The adjustment in the stock price target is a critical indicator of the company's financial health and could influence investor decisions moving forward.
Erste Group initiates coverage on Ecolab stock with Buy rating
PositiveFinancial Markets
Erste Group has started coverage on Ecolab stock, giving it a 'Buy' rating. This is significant as it reflects confidence in Ecolab's business model and growth potential, which could attract more investors and positively impact the stock's performance.
Erste Group upgrades Eli Lilly stock rating to Buy after strong H1 results
PositiveFinancial Markets
Erste Group has upgraded its rating for Eli Lilly to 'Buy' following the company's impressive first half results. This upgrade reflects confidence in Eli Lilly's strong performance and growth potential, which is significant for investors looking for promising stocks in the pharmaceutical sector.
Erste Group downgrades AbbVie stock rating to Hold on guidance cut
NegativeFinancial Markets
Erste Group has downgraded AbbVie's stock rating to 'Hold' following a cut in the company's guidance. This decision reflects concerns about AbbVie's future performance and could impact investor confidence. Such downgrades often lead to fluctuations in stock prices, making it crucial for investors to stay informed about the company's outlook.
Financial Services Roundup: Market Talk
NeutralFinancial Markets
The latest Market Talks provide valuable insights into the financial services sector, focusing on key developments such as the London Stock Exchange Group's performance, the third quarter results of Chinese banks, and updates from Blackstone. These insights are crucial for investors and analysts as they navigate the complexities of the market.